GlassScriptPhysician profile
Aaron M Amburgey
NPI 1265704845
$2,168.27
in general payments reported to CMS, 2019-2025
25 companies · $191 in 2025
The $191 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $178 · 2022: $632 · 2023: $472 · 2024: $695 · 2025: $191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,311 · Travel and Lodging: $47.14.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,310.81 |
| Travel and Lodging | $47.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $431.52 | 2022-2024 | Alto Abdominal Stent Graft System |
| Edwards Lifesciences Corporation | $245.94 | 2022-2025 | Mitris Resilia Mitral Valve, Inspiris Resilia Aortic Valve, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Medical Device Business Services, INC. | $234.41 | 2024 | |
| Atricure, INC. | $192.73 | 2022-2024 | |
| W. L. Gore & Associates, INC. | $187.53 | 2022-2023 | Gore Tag Thoracic Branch Endoprosthesis, Gore Viabahn Vbx Balloon Expandable Endo, Gore Excluder Iliac Branch Endoprosthesis |
| Medtronic, INC. | $105.71 | 2023-2024 | Corevalve Evolut R, Penditure |
| Ethicon US, LLC | $105.66 | 2022-2023 | Echelon Endopath, Prolene, Dermabond |
| Bolton Medical INC | $86.92 | 2024-2025 | Treo Abdominal Stent-Graft System |
| Janssen Pharmaceuticals, INC | $78.22 | 2021 | |
| Boston Scientific Corporation | $60.70 | 2021-2022 | |
| Abbott Laboratories | $57.44 | 2021-2023 | Epic |
| Merck Sharp & Dohme LLC | $57.29 | 2024 | Keytruda |
| Smith+Nephew, INC. | $47.05 | 2025 | Pico 7, Renasys Go V2 Home |
| Cvrx, INC. | $43.67 | 2023-2024 | Barostim Neo System |
| Terumo Cardiovascular Systems Corporation | $38.03 | 2023-2025 | Virtuosaph Plus With Radial Indication, Terumo Advanced Perfusion System 1, Cdi Blood Parameter Monitoring System 550 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $27.20 | 2024 | V.A.C. Veraflo, Prevena |
| Baxter Healthcare | $26.43 | 2023 | Tisseel, Floseal |
| Abiomed | $23.97 | 2024 | Impella |
| Philips North America LLC | $22.49 | 2025 | Vest Therapy Und |
| Talis Clinical LLC | $21.14 | 2024 | |
| La Jolla Pharmaceutical Company | $18.07 | 2021 | |
| Avanos Medical | $16.65 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $16.13 | 2025 | |
| Bard Peripheral Vascular, INC. | $11.82 | 2022 | |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $11.55 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Amburgey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.